fireflyneuro.com (AIFF) - Uzoq muddatli majburiyatlarning kapitalga nisbati

Firefly Neuro - AIFF emitenti grafik logotipi

Firefly Neuroscience, Inc (AIFF) uchun joriy uzoq muddatli qarzdorlikning kapitalga nisbati ko'rsatkichi shuni ko'rsatadiki, oxirgi raqam 0.00 ni tashkil etadi. Firefly Neuroscience, Inc (AIFF) raqamli biomarkerlar orqali ruhiy buzilishlarni ob'ektiv tashxislash uchun BNA AI tahlilini joriy qilmoqda. Zaxira AQSh bulutli ma'lumotlar markazlari B2B xizmatlarining barqarorligini ta'minlaydi. Shu bilan birga, kompaniya miya funksiyalarining yuqori aniqlikdagi skanerlashini avtomatlashtiruvchi BrainScope tizimini joriy etmoqda.

Firefly Neuroscience, Inc. (AIFF): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 30.10.2026gacha

Firefly Neuroscience, Inc (AIFF) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi Firefly Neuroscience, Inc.|AIFF - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Firefly Neuroscience, Inc.|AIFF - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Firefly Neuroscience|AIFF - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati fireflyneuro.com|AIFF - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Firefly Neuroscience, Inc|AIFF - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati fireflyneuro.com|AIFF - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Firefly Neuroscience, Inc.|AIFF - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Firefly Neuroscience|Shoshilinch likvidlik fireflyneuro.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
AIFF - Sof foyda
Kompaniyaning jamlanma tahlili:Firefly Neuroscience, Inc
Firefly Neuro original mahsuloti

Ushbu ko'rsatkich uzoq muddatli majburiyatlarni umumiy kapital bilan solishtirib, moliyaviy barqarorlikning qanchalik darajada tashqi moliyalashtirishga bog'liqligini aniqlaydi. Mazkur metrika emitentning daromadlilikka putur yetkazmagan holda, muddati bir yildan ortiq bo'lgan kreditlarni xizmat ko'rsatish qobiliyatini o'lchaydi. Firefly Neuroscience, Inc (AIFF) uchun bunday qarzlar uning bulutli EEG tahlil platformasini kengaytirishni qo'llab-quvvatlashi mumkin. Uzoq muddatli kreditlarning kapitalga nisbatini tahlil qilish orqali investor investitsiyalar o'sishi va qarz yuklamasi o'rtasidagi muvozanatni baholaydi.

Raqobatdosh kompaniyalar tahlili

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|harmonybiosciences.com - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BHVN|Uzoq muddatli qarzdorlikning kapitalga nisbati Amylyx Pharmaceuticals Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|Uzoq muddatli qarzning kapitalga koeffitsiyenti PRAX|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ceribell.com|PRTA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati ALEC (Alector)|Uzoq muddatli qarzning o'z kapitaliga nisbati Annexon Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati OMER|Uzoq muddatli qarzning o'z kapitaliga nisbati NGNE (Neurogene Inc.)|ACIU - Uzoq muddatli majburiyatlarning kapitalga nisbati|Voyager Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti NMRA|SCLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|TVGN (Tevogen Bio Inc.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ACOG: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati cogrx.com (CGTX)|Uzoq muddatli qarzning o'z kapitaliga nisbati IKT|Uzoq muddatli qarzning kapitalga nisbati Cassava Sciences Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc. (ASRT)|COYA (coyatherapeutics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Vistagen VTGN|Ovid Therapeutics Inc (OVID) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati CervoMed, Inc. CRVO|ATHE: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Clene|PEPG (PepGen Inc) - Uzoq muddatli qarzning kapitalga nisbati|jupiterneurosciences.com (JUNS) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati RLMD|ANVS - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Grace Therapeutics GRCE|KLTO: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|NeuroSense Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|revivapharma.com (RVPH) - Uzoq muddatli qarzning o'z kapitaliga nisbati|MTVA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NeurAxis Inc. (NRXS)|Uzoq muddatli qarzning o'z kapitaliga nisbati HSDT|PASG: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati NEUP|Uzoq muddatli qarzdorlikning kapitalga nisbati minervaneurosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Athira Pharma ATHA|ADXN: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Alzamend - Uzoq muddatli qarzning kapitalga nisbati|Cyclerion Therapeutics (CYCN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PTIX: Uzoq muddatli qarzning kapitalga nisbati|Pasithea Therapeutics Corp. (KTTA) - Uzoq muddatli qarzning kapitalga nisbati|CRGT (Cortigent Inc) - Uzoq muddatli qarzning kapitalga nisbati|Avenue Therapeutics Inc. (ATXI) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati BCLI|CARA: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati CHRO (Chromocell Therapeutics)|ELYM (Eliem Therapeutics, Inc.) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH (Longboard Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|MRNS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NKGen Biotech Corp (NKGN)|Uzoq muddatli qarzning o'z kapitaliga nisbati NRBO|Uzoq muddatli qarzning kapitalga nisbati sagerx.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|TRVN (Trevena Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical Inc. (WENA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati